Works about ANAPLASTIC lymphoma kinase

Results: 1928

3 Things You Should Know About Managing ALK+ Metastatic NSCLC.
Published in:
Oncology (08909091), 2025, v. 39, n. 2, p. 76
Publication type:
Article
A novel automated IHC staining system for quality control application in ALK immunohistochemistry testing.
Published in:
Pathology & Oncology Research, 2025, p. 1, doi. 10.3389/pore.2025.1611964
By:
- Chunxiao Hou;
- Xueru Song;
- Hongwei Chen;
- Chengdong Chang;
- Jinfeng Lu;
- Cheng Li;
- Haiyan Qu;
- Rui Guo;
- Jingyi Xu;
- Liming Xu
Publication type:
Article
Development of an ALK-positive Non-Small-Cell Lung Cancer in Vitro Tumor 3D Culture Model for Therapeutic Screening.
Published in:
Journal of Histochemistry & Cytochemistry, 2025, v. 73, n. 1/2, p. 63, doi. 10.1369/00221554251318435
By:
- Berry, Madeleine A.;
- Bland, Abigail R.;
- Major, Gretel S.;
- Ashton, John C.
Publication type:
Article
Ciljana terapija u liječenju bolesnika s metastatskim karcinomom pluća nemalih stanica i mutacijom gena ALK.
Published in:
Medicina Fluminensis, 2025, v. 61, n. 1, p. 11, doi. 10.21860/medflum2025_323581
By:
- Ćurić, Melany;
- Prica, Vuk
Publication type:
Article
Predictors of occult lymph node metastasis in clinical T1 lung adenocarcinoma: a retrospective dual-center study.
Published in:
BMC Pulmonary Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12890-025-03559-3
By:
- Huang, Xiaoxin;
- Huang, Xiaoxiao;
- Wang, Kui;
- Liu, Lijuan;
- Jin, Guanqiao
Publication type:
Article
Laparoscopic partial cystectomy using stapling system for inflammatory myofibroblastic tumor of urinary bladder: A case report.
Published in:
2025
By:
- Nishiyama, Hiroki;
- Ito, Kozue;
- Hasegawa, Go;
- Ikeda, Yohei;
- Ishida, Kyohei;
- Hara, Noboru;
- Nishiyama, Tsutomu
Publication type:
Case Study
Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation.
Published in:
Angewandte Chemie, 2023, v. 135, n. 13, p. 1, doi. 10.1002/ange.202217246
By:
- Xie, Shaowen;
- Zhan, Feiyan;
- Zhu, Jingjie;
- Sun, Yuan;
- Zhu, Huajian;
- Liu, Jie;
- Chen, Jian;
- Zhu, Zheying;
- Yang, Dong‐Hua;
- Chen, Zhe‐Sheng;
- Yao, Hong;
- Xu, Jinyi;
- Xu, Shengtao
Publication type:
Article
The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan.
Published in:
2021
By:
- Okada, Kouji;
- Usui, Kensuke;
- Kikuchi, Daisuke;
- Takahashi, Masanori;
- Watanabe, Yoshiteru
Publication type:
Letter
Variable ALK Protein and ALK Gene Staining in Inflammatory Myofibroblastic Tumors.
Published in:
2013
By:
- KATZMAN, PHILIP J.
Publication type:
Letter
Inflammatory Myofibroblastic Tumor of the Lung in Children: Anaplastic Lymphoma Kinase (ALK) Expression and Clinico-Pathological Correlation.
Published in:
Pediatric & Developmental Pathology, 2012, v. 15, n. 3, p. 179, doi. 10.2350/11-10-1105-OA.1
By:
- Siminovich, Mónica;
- Galluzzo, Laura;
- López, Jessica;
- Lubieniecki, Fabiana;
- De Dávila, Maria Teresa G.
Publication type:
Article
Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.
Published in:
Surgery Today, 2016, v. 46, n. 9, p. 1091, doi. 10.1007/s00595-015-1295-z
By:
- Ohba, Taro;
- Toyokawa, Gouji;
- Osoegawa, Atsushi;
- Hirai, Fumihiko;
- Yamaguchi, Masafumi;
- Taguchi, Ken-ichi;
- Seto, Takashi;
- Takenoyama, Mitsuhiro;
- Ichinose, Yukito;
- Sugio, Kenji
Publication type:
Article
The role of NLRP1 and NLRP3 inflammasomes in the etiopathogeneses of pityriasis lichenoides chronica and mycosis fungoides: an immunohistochemical study.
Published in:
Archives of Dermatological Research, 2023, v. 315, n. 2, p. 231, doi. 10.1007/s00403-022-02363-x
By:
- Bostan, Ecem;
- Gokoz, Ozay;
- Atakan, Nilgun
Publication type:
Article
Discovery of anaplastic lymphoma kinase inhibitors from natural product library: A holistic in silico approach.
Published in:
Biotechnology & Applied Biochemistry, 2021, v. 68, n. 6, p. 1185, doi. 10.1002/bab.2040
By:
- Subburaj, Saranyadevi;
- Nagrale, Tanvi Anand;
- Khan, Mohd. Mustufa;
- James, Nivya;
- Karuppasamy, Ramanathan;
- Veerappapillai, Shanthi
Publication type:
Article
The complete mitochondrial genome of Pyxicephalus adspersus: high gene rearrangement and phylogenetics of one of the world's largest frogs.
Published in:
PeerJ, 2019, p. 1, doi. 10.7717/peerj.7532
By:
- Yin-Yin Cai;
- Shi-Qi Shen;
- Li-Xu Lu;
- Storey, Kenneth B.;
- Dan-Na Yu;
- Jia-Yong Zhang
Publication type:
Article
Oncologists Push Beyond New Lung Cancer Genomic Testing Guidelines.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/djv023
By:
- Garber, Ken
Publication type:
Article
Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 10, p. 1, doi. 10.1093/jnci/dju256
By:
- Schink, Julian C.;
- Trosman, Julia R.;
- Weldon, Christine B.;
- Siziopikou, Kalliopi P.;
- Tsongalis, Gregory J.;
- Rademaker, Alfred W.;
- Patel, Jyoti D.;
- Benson III, Al B.;
- Perez, Edith A.;
- Gradishar, William J.
Publication type:
Article
ALK1 as a Novel Therapeutic Target for CD30+T-Anaplastic Large Cell Lymphoma.
Published in:
2014
By:
- Hsu, Jack W.;
- Dang, Nam H.
Publication type:
Editorial
Crizotinib in Advanced, Chemoresistant Anaplastic Lymphoma Kinase--Positive Lymphoma Patients.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 2, p. 1, doi. 10.1093/jnci/djt378
By:
- Gambacorti Passerini, Carlo;
- Farina, Francesca;
- Stasia, Alessandra;
- Redaelli, Sara;
- Ceccon, Monica;
- Mologni, Luca;
- Messa, Cristina;
- Guerra, Luca;
- Giudici, Giovanni;
- Sala, Elena;
- Mussolin, Lara;
- Deeren, Dries;
- King, Michael H.;
- Steurer, Michael;
- Ordemann, Rainer;
- Cohen, Amos M.;
- Grube, Matthias;
- Bernard, Lea;
- Chiriano, Gianpaolo;
- Antolini, Laura
Publication type:
Article
ALK Gene Amplified in Most Inflammatory Breast Cancers.
Published in:
JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 2, p. 87, doi. 10.1093/jnci/djr553
By:
- Tuma, Rabiya S.
Publication type:
Article
Discovery of novel anaplastic lymphoma kinase (ALK) and histone deacetylase (HDAC) dual inhibitors exhibiting antiproliferative activity against non-small cell lung cancer.
Published in:
Journal of Enzyme Inhibition & Medicinal Chemistry, 2024, v. 39, n. 1, p. 1, doi. 10.1080/14756366.2024.2318645
By:
- Wang, Kang-Li;
- Yeh, Tsung-Yu;
- Hsu, Pei-Chen;
- Wong, Tzu-Hsuan;
- Liu, Jia-Rong;
- Chern, Ji-Wang;
- Lin, Miao-Hsia;
- Yu, Chao-Wu
Publication type:
Article
Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer.
Published in:
Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 2512, doi. 10.1080/14756366.2022.2121822
By:
- Dafeng Guo;
- Yu Yu;
- Binyu Long;
- Ping Deng;
- Dongzhi Ran;
- Lei Han;
- Jiecheng Zheng;
- Zongjie Gan
Publication type:
Article
Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors.
Published in:
Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 1426, doi. 10.1080/14756366.2019.1639694
By:
- Nam, Yunju;
- Hwang, Dongkeun;
- Kim, Namdoo;
- Seo, Hong-Seog;
- Selim, Khalid B.;
- Sim, Taebo
Publication type:
Article
Major pathologic response to alectinib in ALK-rearranged adenocarcinoma of the lung.
Published in:
Surgical Case Reports, 2018, v. 4, n. 1, p. 0, doi. 10.1186/s40792-018-0430-7
By:
- Imanishi, Naoko;
- Yoneda, Kazue;
- Taira, Akihiro;
- Ichiki, Yoshinobu;
- Sato, Naoko;
- Hisaoka, Masanori;
- Tanaka, Fumihiro
Publication type:
Article
Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report.
Published in:
Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0322-2
By:
- Takamori, Shinkichi;
- Yamaguchi, Masafumi;
- Taguchi, Kenichi;
- Edagawa, Makoto;
- Shimamatsu, Shinichiro;
- Toyozawa, Ryo;
- Nosaki, Kaname;
- Hirai, Fumihiko;
- Seto, Takashi;
- Takenoyama, Mitsuhiro;
- Ichinose, Yukito
Publication type:
Article
ALECTINIB TREATMENT OF ALK POSITIVE NON SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: OUR CLINICAL EXPERIENCE.
Published in:
Contributions / Prilozi (1857-9345), 2020, v. 41, n. 2, p. 29, doi. 10.2478/prilozi-2020-0030
By:
- Crvenkova, Simonida
Publication type:
Article
ALECTINIB TREATMENT OF ALK POSITIVE NON SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: OUR CLINICAL EXPERIENCE.
Published in:
Contributions / Prilozi (1857-9345), 2020, v. 41, n. 2, p. 29, doi. 10.2478/prilozi-2020-0030
By:
- Crvenkova, Simonida
Publication type:
Article
Analysis of Multigene Mutations in Lung Adenocarcinoma in Zunyi.
Published in:
BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9939065
By:
- Ma, Qingqing;
- Ma, Dengming;
- Lin, Mu;
- Gong, Yadong;
- Han, Xiaojing;
- Chen, Yunhua;
- Tang, Zhu;
- Liu, Mubo
Publication type:
Article
The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00872-0
By:
- Kouroukli, Alexandra G.;
- Fischer, Anja;
- Kretzmer, Helene;
- Chteinberg, Emil;
- Rajaram, Nivethika;
- Glaser, Selina;
- Kolarova, Julia;
- Bashtrykov, Pavel;
- Mathas, Stephan;
- Drexler, Hans G.;
- Ohno, Hitoshi;
- Ammerpohl, Ole;
- Jeltsch, Albert;
- Siebert, Reiner;
- Bens, Susanne
Publication type:
Article
Establishment of potential reference measurement procedure and reference materials for EML4-ALK fusion variants measurement.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-76618-0
By:
- Yang, Yi;
- Zhang, Yu;
- Zhou, Shujun;
- Wang, Xia;
- Niu, Chunyan;
- Zhang, Yongzhuo;
- Gao, Huafang;
- Jin, Xiaohua;
- Wang, Shangjun;
- Du, Meihong;
- Cheng, Xiaoyan;
- Zhu, Lingxiang;
- Dong, Lianhua
Publication type:
Article
Novel therapeutic strategies for rare mutations in non-small cell lung cancer.
Published in:
Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61087-2
By:
- Gou, Qitao;
- Gou, Qiheng;
- Gan, Xiaochuan;
- Xie, Yuxin
Publication type:
Article
Lysophosphatidic Acid Stimulates Mitogenic Activity and Signaling in Human Neuroblastoma Cells through a Crosstalk with Anaplastic Lymphoma Kinase.
Published in:
Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 631, doi. 10.3390/biom14060631
By:
- Dedoni, Simona;
- Olianas, Maria C.;
- Onali, Pierluigi
Publication type:
Article
Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.
Published in:
Biomolecules (2218-273X), 2023, v. 13, n. 10, p. 1490, doi. 10.3390/biom13101490
By:
- Katic, Luka;
- Priscan, Anamarija
Publication type:
Article
Tyrosine Kinase Inhibitors Target B Lymphocytes.
Published in:
Biomolecules (2218-273X), 2023, v. 13, n. 3, p. 438, doi. 10.3390/biom13030438
By:
- Upfold, Nikki Lyn Esnardo;
- Petakh, Pavlo;
- Kamyshnyi, Aleksandr;
- Oksenych, Valentyn
Publication type:
Article
A Rare Cause of Gastric Subepithelial Tumor.
Published in:
Clinical Endoscopy, 2020, v. 53, n. 3, p. 377, doi. 10.5946/ce.2020.134
By:
- Gwang Ha Kim;
- Do Youn Park
Publication type:
Article
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK -Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study.
Published in:
Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00057
By:
- Li, Hailin;
- Zhang, Rui;
- Wang, Siwen;
- Fang, Mengjie;
- Zhu, Yongbei;
- Hu, Zhenhua;
- Dong, Di;
- Shi, Jingyun;
- Tian, Jie
Publication type:
Article
The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01301
By:
- Rødland, Gro Elise;
- Melhus, Katrine;
- Generalov, Roman;
- Gilani, Sania;
- Bertoni, Francesco;
- Dahle, Jostein;
- Syljuåsen, Randi G.;
- Patzke, Sebastian
Publication type:
Article
Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center.
Published in:
Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01116
By:
- Liu, Chang;
- Yu, Hui;
- Long, Qianqian;
- Chen, Haiquan;
- Li, Yuan;
- Zhao, Weixin;
- Zhao, Kuaile;
- Zhu, Zhengfei;
- Sun, Si;
- Fan, Min;
- Chang, Jianhua;
- Wang, Jialei
Publication type:
Article
Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors.
Published in:
Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.01026
By:
- Poddubskaya, Elena;
- Bondarenko, Alexey;
- Boroda, Alexander;
- Zotova, Evgenia;
- Glusker, Alex;
- Sletina, Svetlana;
- Makovskaia, Luidmila;
- Kopylov, Philipp;
- Sekacheva, Marina;
- Moisseev, Alexey;
- Baranova, Madina
Publication type:
Article
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer.
Published in:
Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00880
By:
- Lin, Yen-Ting;
- Liu, Yi-Nan;
- Shih, Jin-Yuan
Publication type:
Article
Alectinib, an Anaplastic Lymphoma Kinase Inhibitor, Abolishes ALK Activity and Growth in ALK-Positive Neuroblastoma Cells.
Published in:
Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00579
By:
- Alam, Muhammad Wasi;
- Borenäs, Marcus;
- Lind, Dan E.;
- Cervantes-Madrid, Diana;
- Umapathy, Ganesh;
- Palmer, Ruth H.;
- Hallberg, Bengt
Publication type:
Article
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00275
By:
- Vivancos Stalin, Lucie;
- Gualandi, Marco;
- Schulte, Johannes Hubertus;
- Renella, Raffaele;
- Shakhova, Olga;
- Mühlethaler-Mottet, Annick
Publication type:
Article
Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8+ T cell responses in children with NPM-ALK+ anaplastic large cell lymphoma.
Published in:
Clinical & Experimental Immunology, 2016, v. 186, n. 1, p. 96, doi. 10.1111/cei.12842
By:
- K. Singh, V.;
- Werner, S.;
- Hackstein, H.;
- Lennerz, V.;
- Reiter, A.;
- Wölfel, T.;
- Damm‐Welk, C.;
- Woessmann, W.
Publication type:
Article
Redefining Recovery: The Transformative Impact of the ALINA Trial on Adjuvant Therapy for ALK-Positive Non-Small Cell Lung Cancer.
Published in:
Lung Cancer: Targets & Therapy, 2024, v. 15, p. 129, doi. 10.2147/LCTT.S478054
By:
- Arter, Zhaohui Liao;
- Nagasaka, Misako
Publication type:
Article
Overcoming Central β-Sheet &num;6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver.
Published in:
Lung Cancer: Targets & Therapy, 2024, v. 15, p. 19, doi. 10.2147/LCTT.S446878
By:
- Lee, Alexandria TM;
- Ou, Sai-Hong Ignatius
Publication type:
Article
Overcoming Central β-Sheet &num;6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver.
Published in:
Lung Cancer: Targets & Therapy, 2024, v. 15, p. 19, doi. 10.2147/LCTT.S446878
By:
- Lee, Alexandria TM;
- Ou, Sai-Hong Ignatius
Publication type:
Article
ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia.
Published in:
Lung Cancer: Targets & Therapy, 2023, v. 14, p. 71, doi. 10.2147/LCTT.S419395
By:
- Lee, Alexandria TM;
- Ou, Saihong Ignatius
Publication type:
Article
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors.
Published in:
Lung Cancer: Targets & Therapy, 2020, v. 11, p. 33, doi. 10.2147/LCTT.S239675
By:
- Schrock, Alexa B;
- Madison, Russell;
- Rosenzweig, Mark;
- Allen, Justin M;
- Erlich, Rachel L;
- Wang, Siao-Yi;
- Chidiac, Tarek;
- Reddy, Vodur Suresh;
- Riess, Jonathan W;
- Yassa, Ahmet Ersin;
- Shakir, Abdur;
- Miller, Vincent A;
- Alexander, Brian M;
- Venstrom, Jeffrey;
- McGregor, Kimberly;
- Ali, Siraj M
Publication type:
Article
Symptomatic CNS Radiation Necrosis Requiring Neurosurgical Resection During Treatment with Lorlatinib in ALK-Rearranged NSCLC: A Report of Two Cases.
Published in:
Lung Cancer: Targets & Therapy, 2020, v. 11, p. 13, doi. 10.2147/LCTT.S224991
By:
- Zhu, Viola W;
- Nagasaka, Misako;
- Kubota, Takafumi;
- Raval, Kunil;
- Robinette, Natasha;
- Armas, Octavio;
- Al-Holou, Wajd;
- Ou, Sai-Hong Ignatius
Publication type:
Article
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.
Published in:
Lung Cancer: Targets & Therapy, 2019, v. 10, p. 125, doi. 10.2147/LCTT.S209231
By:
- Gadgeel, Shirish;
- Shaw, Alice T;
- Barlesi, Fabrice;
- Crino, Lucio;
- Yang, James CH;
- Dingemans, Anne-Marie;
- Kim, Dong-Wan;
- Marinis, Filippo de;
- Schulz, Mathias;
- Liu, Shiyao;
- Gupta, Ravindra;
- Smoljanovic, Vlatka;
- Ou, Sai-Hong Ignatius
Publication type:
Article
TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations.
Published in:
Lung Cancer: Targets & Therapy, 2019, v. 10, p. 81, doi. 10.2147/LCTT.S212406
By:
- Ouseph, Madhu M;
- Taber, Angela;
- Khurshid, Humera;
- Madison, Russell;
- Aswad, Bassam I;
- Resnick, Murray B;
- Yakirevich, Evgeny;
- Ali, Siraj M;
- Patel, Nimesh R
Publication type:
Article